Neuren Pharmaceuticals | NEU - Ebitda


Neuren Pharmaceuticals reported AUD11.14M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Avita Medical AUD -5.56M 4.13M Jun/2026
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Dianthus Therapeutics USD -61.38M 14.92M Jun/2026
Genetic Signatures AUD -7.11M 970K Dec/2024
Ionis Pharmaceuticals USD -95.22M 9.99M Sep/2026
Medical Developments International AUD 1.78M 3.78M Dec/2024
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Organon & Co USD 502M 131M Sep/2026
PYC Therapeutics AUD -22.79M 1.5M Dec/2025
Starpharma Holdings AUD -4.85M 1.73M Dec/2024
Tectonic Therapeutic USD -21.18M 365K Dec/2025
Telix Pharmaceuticals AUD 76.49M 58.07M Jun/2026
Viatris USD 1.2B 7.4M Sep/2026
Xeris Pharmaceuticals USD -20.94M 33.27M Jun/2026